4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-002522
Chief Financial Officer sold 12,400 shares at $7.75 ($96,100)
- Chief Financial Officer acquired 12,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-12 | Option exercise | +12,400 | $4.69 | $58,156 | 241,038 | D: show line 1 in the form |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-12 | Sale | −12,400 | $7.75 | $96,100 | 228,638 | D: show line 2 in the form |
| Open-market sales · 12,400 sh · avg $7.75 · $96,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-12 | Option exercise · Stock Option (Right to Buy) | −12,400 | 37,200 | D: show line 3 in the form |
Loading xslF345X03/tv483528_4.xml…